Correlation Between Lyell Immunopharma and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyell Immunopharma and C4 Therapeutics, you can compare the effects of market volatilities on Lyell Immunopharma and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and C4 Therapeutics.
Diversification Opportunities for Lyell Immunopharma and C4 Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lyell and CCCC is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Lyell Immunopharma and C4 Therapeutics
Given the investment horizon of 90 days Lyell Immunopharma is expected to under-perform the C4 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Lyell Immunopharma is 1.58 times less risky than C4 Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The C4 Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 323.00 in C4 Therapeutics on August 29, 2024 and sell it today you would earn a total of 96.00 from holding C4 Therapeutics or generate 29.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyell Immunopharma vs. C4 Therapeutics
Performance |
| Timeline |
| Lyell Immunopharma |
| C4 Therapeutics |
Lyell Immunopharma and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyell Immunopharma and C4 Therapeutics
The main advantage of trading using opposite Lyell Immunopharma and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |